Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 93   

Articles published

GALE 1.38 -0.03 (-2.13%)
price chart
Company Update (NASDAQ:GALE): Galena Biopharma Inc Expands Patient ...
Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced that human ...
Galena expands patient population in NeuVax breast cancer trial (GALE)  Seeking Alpha (registration)
Technical Scrutiny on Biotech Stocks -- Exact Sciences, Galena Biopharma ...
Over the last three trading sessions and over the past three months, Galena Biopharma Inc.'s shares have declined 3.42% and 5.37%, respectively.
MLV Pounds the Table on Galena Biopharma Inc
MLV analyst Vernon Bernardino was out pounding the table on Galena Biopharma Inc (NASDAQ:GALE) Monday, reiterating a Buy rating and a $5 price target, which implies an upside of 236% from current levels.
MLV & Co Analysts Give Galena Biopharma a $5.00 Price Target (GALE)  Dakota Financial News
Cantor Remains Cautious on Galena Biopharma Inc Following 4Q Earnings
In a research report issued today, Cantor analyst Mara Goldstein maintained a Sell rating on Galena Biopharma Inc (NASDAQ:GALE) with a $2.00 price target, following the company's fourth-quarter results, posting earnings of ($0.06) per share on revenues ...
Technical Report on Galena Biopharma, Inc. (NASDAQ:GALE)  Markets Wired
Galena Biopharma (GALE) Tops Views  Wall Street Pit
Galena Biopharma Inc (GALE) Releases Q4 Report Amid SEC Investigation
Galena Biopharma (NASDAQ: GALE) reported fourth quarter and year-end 2014 results on March 5th. The biopharmaceutical company specializes in oncology drugs and saw significant advancements in NeuVax, a drug used to prevent recurring cancers in ...
Galena Biopharma (GALE) Falls: Stock Goes Down 6%  Zacks.com
First Call Rating Update on Galena Biopharma, Inc.  Stafford Daily
Commentary On Drowning Stock's Performance - Galena Biopharma Inc ...
Fura Emeralds Inc. (GALE), a biopharmaceutical corporation developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, declared the pricing of an underwritten ...
Morning Best Stocks: Galena Biopharma, Inc. (GALE), CTI BioPharma Corp ...  WallStreet Scope
Healthcare Stocks News Review: Pfizer (PFE), CTI BioPharma (CTIC), Galena ...  Techsonian (press release)
Canada Stocks Fell: Galena Biopharma , (GALE), Turquoise Hill Resources ...
Canadian stocks fell the most in two weeks, following a three-day rally, as a decline in banks and Valeant Pharmaceuticals International Inc. overshadowed gains in energy shares. Valeant dropped 3.4 percent for a second straight decline after unit ...
Galena Biopharma Announces Closing of Public Offering of Common Stock and ...
Galena Biopharma, Inc. GALE, +2.92% a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced the closing of its ...
Galena Biopharma Inc. (GALE) is Trading Lower on Unusual Volume for March 06
Galena Biopharma Inc. ($GALE) experienced unusually high volume on Mar. 06, as the stock lost 6% to a closing price of $1.88.
Galena Biopharma Announces Pricing of Public Offering of Common Stock and ...
Galena Biopharma, Inc. GALE, -2.14% is a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care.
Company Update (NASDAQ:GALE): Galena Biopharma Announces Pricing of ...  Smarter Analyst